Why Millennium Decided Take-Out Affy Tasted Better than Homemade Array Recipe | GenomeWeb

Within the next year to 18 months, Millennium Pharmaceuticals will switch over to the Affymetrix platform for most of the 4,000 to 5,000 arrays it uses each month, Craig Muir, vice president of platform technology for Millennium said during a keynote address to the Chips to Hits conference in San Diego this week.

The reasons for this switch, which both companies announced last week, are both economic and technological, according to Muir.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.